Question

What are the issues raised by patenting of onco-mouse?

26 Nov 2020
Answer :
Word Count : 495

The granting of an American patent in 1988 concerning the transgenic mouse or Harvard (Onco-) Mouse was very controversial and gave rise to a very strong, emotional reaction in the US, even though the USPTO only applied an earlier Supreme Court decision in the Diamond versus Chakraborty case of 1980, concerning a genetically modified bacteria used for the degradation of hydrocarbons.

When the European Patent Office had to examine the Harvard case, its first decision was a rejection of the patent application, on July 14, 1989; the grounds for this rejection were articles 53(b) (non-patentable subject matter) and 83 (insufficiency of disclosure). Article 53(a) (violation of ordre public and morality) was only cited by the Examining Division but was not specified as a __________ _______ _______ _________ ________ ____.
______ __________ __________ __________ __________ ____ ________ _____.
_____ _______ _______ _____ _________ _____ ____ __________ __________ _____ ___.
_________ _______ ________ ______ _______.
________ ___ ____ ____ _____ _____.
_______ ______ _____ _________ ______ __________ _________ ________ _________ _________ _____.
___ ___ ___ _______ _________ _______ _____ ____ _______ _________ _____ _____.
__________ _____ __________ ____ _________ ____ ______ ________ _________ _____.
______ ____ _________ ________ ________ _______ _________ ____ _______.
______ ___ __________ _____ __________ _________ ______ ______.
______ _______ __________ ____ ____.
___ _______ _____ ______ ________.
________ ______ ______ __________ __________ __________ ______ _______.
___ ________ ________ ______ _______.
__________ _______ ___ __________ ____ ______.
_________ ___ ________ _______ __________ ___ _______ _________ __________ ___ _________.
_____ _____ _________ ______ _______.
____ ________ _____ ___ ________ ______ _____.
__________ ____ ______ ____ ________ _________ ___ _______.
_____ ___ ______ ______ ________ ______ ______.
__________ ____ _____ ______ ____ ______ _________ ____ _______ _______ ______.
____ ____ _________ __________ _________ _________ ______.
___ ___ __________ ______ ______ ___.
______ _______ _____ _________ ____ _______.
__________ _______ _____ _______ ____ __________ ______ ________.
________ ________ ____ _________ ____ ____ ______ ________ ________ __________ ___.
___ ______ __________ _________ ______ _____.
__________ _____ ___ _______ __________ _______ _____ _____ ___.
__________ ________ ______ _________ ___ __________ ___ _________.
_____ ___ _________ _________ ____ _______ _______ _______ _____ _______ ________.
_______ ____ _______ ___ _____ __________ __________ _____.
________ __________ _________ ___ ___.
__________ __________ ______ ________ _______ ________ ______ ____ ______ _______.
______ ___ ______ ________ ____ ____ _______.
________ ______ _________ ______ ____ ______ ______ ____ _______ _________ ______ ______.
_____ ___ ___ __________ _______ ___ _____ ________ _______ ________.
______ ___ ____ ___ _______ ______ _______.
_________ _______ ________ ________ ____.
________ ______ _______ _________ ____ ________ __________.
_____ _______ _________ ______ _____ _________ _______ ______ ____ _____ _________.
_________ ___ __________ ________ _______ ___ _____ ________ ______ ______.
_____ __________ _________ _____ ___ ________ _________ _______ ____ _____.
__________ _____ _____ ____ ___ _______ ________.
_______ ___ _____ _______ __________ _____.
________ ________ ______ _______ ________ ________ _________.
_______ _______ _________ _____ ______ ______ ___ ________ __________ __________ __________.
______ ______ ______.
Get Full Answer on WhatsApp

IGNOU NEWS
Assignment Submission Last Date Extended Till 30 June 2026 Click Here★★★IGNOU June 2026 TEE Date Sheet Released Click Here★★★
Top
📞
Call Support Instant phone assistance What are the issues raised by patenting of onco-mouse?
🟢
WhatsApp Chat Fast live messaging
Email Us Business enquiries & support